Danaher Corporation vs Frontline Plc Ordinary Shares — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Frontline Plc Ordinary Shares trades at $56.1 (market cap $12.52B). The key difference: Danaher Corporation is far larger — about 12.2× Frontline Plc Ordinary Shares's market cap, and Frontline Plc Ordinary Shares pays the higher dividend (9.56%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Frontline Plc Ordinary Shares for 0 Days on average.
| DHR | FRO | |
|---|---|---|
Market Cap | $152.87B | $12.52B |
Volume | 5,228,698 | 6,375,509 |
Sector | Health | Industrials |
52-Week High | $242.05 | $56.26 |
52-Week Low | $161.91 | $20.58 |
Typical Hold Time | 69 Days | 0 Days |
Enterprise Value | $175.08B | $14.64B |
Dividend Yield | 0.74% | 9.56% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.
Read more on FRO →